T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Schlumberger
SLB
|
+$2.5B |
| 2 |
Kenvue
KVUE
|
+$1.3B |
| 3 |
Halliburton
HAL
|
+$1.16B |
| 4 |
Charles Schwab
SCHW
|
+$836M |
| 5 |
Boeing
BA
|
+$832M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.52B |
| 2 |
Apple
AAPL
|
+$1.77B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.57B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.47B |
| 5 |
Intuit
INTU
|
+$1.14B |
Sector Composition
| 1 | Technology | 29.85% |
| 2 | Healthcare | 16.84% |
| 3 | Financials | 10.89% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVNC
2026
DELISTED
Revance Therapeutics, Inc.
RVNC
| $578K | ﹤0.01% |
50,378
+4,838
| +11% | +$55.5K |
|
2027
Liberty Broadband Class A
LBRDA
$8.65B
| $574K | ﹤0.01% |
6,307
+211
| +3% | +$19.2K |
|
2028
Utz Brands
UTZ
$1.12B
| $572K | ﹤0.01% |
42,580
+3,491
| +9% | +$46.9K |
|
2029
ATN International
ATNI
$238M
| $571K | ﹤0.01% |
18,066
-2,321
| -11% | -$73.4K |
|
2030
Artivion
AORT
$1.92B
| $569K | ﹤0.01% |
37,488
+1,024
| +3% | +$15.5K |
|
2031
ePlus
PLUS
$1.97B
| $569K | ﹤0.01% |
8,955
+740
| +9% | +$47K |
|
2032
Gray Television
GTN
$598M
| $568K | ﹤0.01% |
82,060
+13,645
| +20% | +$94.4K |
|
2033
Nu Skin
NUS
$596M
| $568K | ﹤0.01% |
26,750
+2,357
| +10% | +$50K |
|
|
CLDT
2034
Chatham Lodging
CLDT
$348M
| $566K | ﹤0.01% |
59,046
+1,380
| +2% | +$13.2K |
|
2035
Marathon Digital Holdings
MARA
$6.04B
| $566K | ﹤0.01% |
66,476
+10,451
| +19% | +$89K |
|
|
MCBC
2036
DELISTED
Macatawa Bank Corp
MCBC
| $565K | ﹤0.01% |
63,058
+662
| +1% | +$5.93K |
|
2037
TETRA Technologies
TTI
$630M
| $565K | ﹤0.01% |
88,557
-8,782
| -9% | -$56K |
|
2038
LiveRamp
RAMP
$1.73B
| $564K | ﹤0.01% |
19,533
+2,033
| +12% | +$58.7K |
|
2039
West Bancorporation
WTBA
$344M
| $564K | ﹤0.01% |
34,547
+631
| +2% | +$10.3K |
|
2040
Golar LNG
GLNG
$4.16B
| $561K | ﹤0.01% |
23,084
+2,499
| +12% | +$60.7K |
|
2041
Arcus Biosciences
RCUS
$1.23B
| $561K | ﹤0.01% |
31,213
-250,407
| -89% | -$4.5M |
|
2042
Under Armour Class C
UA
$2.04B
| $561K | ﹤0.01% |
87,760
+5,874
| +7% | +$37.5K |
|
2043
Chegg
CHGG
$167M
| $560K | ﹤0.01% |
62,684
+1,408
| +2% | +$12.6K |
|
2044
Live Oak Bancshares
LOB
$1.67B
| $560K | ﹤0.01% |
19,315
| – | – |
|
|
CTEV
2045
Claritev Corporation
CTEV
$1.01B
| $558K | ﹤0.01% |
8,293
+254
| +3% | +$17.1K |
|
|
EVBG
2046
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $557K | ﹤0.01% |
24,831
+1,992
| +9% | +$44.7K |
|
2047
MVB Financial
MVBF
$305M
| $554K | ﹤0.01% |
24,526
+447
| +2% | +$10.1K |
|
2048
Lakeland Financial Corp
LKFN
$1.66B
| $550K | ﹤0.01% |
11,573
+550
| +5% | +$26.1K |
|
|
PRSU
2049
Pursuit Attractions and Hospitality, Inc.
PRSU
$1.04B
| $549K | ﹤0.01% |
20,934
+396
| +2% | +$10.4K |
|
2050
First Business Financial Services
FBIZ
$431M
| $548K | ﹤0.01% |
18,240
-4,924
| -21% | -$148K |
|